๐Ÿ”Ž Trials Near Me

Home โ€บ Paraganglioma

Paraganglioma clinical trials recruiting in the U.S.

14 studies for Paraganglioma are recruiting participants at sites across the United States.

Cities with the most studies

By state

Recently updated studies

Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma

RecruitingPhase 2
Ages 18 to 100 ยท All sexes ยท Updated Aug 25, 2026 ยท NCT03206060

Using the EHR to Advance Genomic Medicine Across a Diverse Health System

Recruiting
Ages 18 and older ยท All sexes ยท Updated Aug 14, 2026 ยท NCT06377033

Familial Investigations of Childhood Cancer Predisposition

RecruitingObservational study
All ages ยท All sexes ยท Updated Jun 17, 2026 ยท NCT03050268

Study of ONC206 (JZP3507) in Advanced Pheochromocytoma and Paraganglioma

RecruitingPhase 2
Ages 18 and older ยท All sexes ยท Updated Jun 10, 2026 ยท NCT07282587

18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection

RecruitingPhase 2
Ages 18 to 120 ยท All sexes ยท Updated May 19, 2026 ยท NCT06503146

Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors

RecruitingPhase 1/2
Ages 18 to 90 ยท All sexes ยท Updated May 14, 2026 ยท NCT05636618

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

RecruitingPhase 1
Ages 18 to 75 ยท All sexes ยท Updated Mar 17, 2026 ยท NCT04119024

In Vivo PARP-1 Expression With 18F-FluorThanatrace PET/CT in Patients With Pheochromocytoma and Paraganglioma

RecruitingEarly phase 1
Ages 18 and older ยท All sexes ยท Updated Feb 27, 2026 ยท NCT05636540

68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors.

RecruitingPhase 4
Ages 18 to 100 ยท All sexes ยท Updated Nov 21, 2025 ยท NCT04081701

Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions

RecruitingObservational studyHealthy volunteers welcome
All ages ยท All sexes ยท Updated Oct 15, 2025 ยท NCT03160274

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.